ABCG4: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 22: | Line 22: | ||
[[Category:ATP-binding cassette transporters]] | [[Category:ATP-binding cassette transporters]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 03:00, 17 March 2025
ABCG4 is a gene that in humans encodes the ATP-binding cassette sub-family G member 4 protein. This protein is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes.
Function[edit]
The ABCG4 protein is a half-transporter that likely plays a role in multi-drug resistance. Half-transporters, like ABCG4, are believed to function as homodimers or heterodimers. ABCG4 is expressed in several tissues, with the highest expression in the brain and retina. It is thought to play a role in the transport of lipids and sterols, which are essential for normal brain function and vision.
Clinical significance[edit]
Mutations in the ABCG4 gene have been associated with several diseases. For example, a mutation in this gene has been linked to Stargardt disease, a form of juvenile macular degeneration. Additionally, ABCG4 has been implicated in the development of atherosclerosis, as it may play a role in the efflux of cholesterol from cells.
Research[edit]
Research into the function and potential therapeutic applications of ABCG4 is ongoing. For example, studies are investigating whether modulating the activity of ABCG4 could be a potential treatment strategy for diseases such as atherosclerosis and Stargardt disease.
See also[edit]
References[edit]
<references />
